Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07465029 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion pushed from May 31, 2026 to Nov 27, 2026 Primary completion date changed from estimate of Mar 31, 2026 to Apr 23, 2026 · Eligibility criteria expanded, about 12 words · Secondary endpoints: details revised at 4 of 23 entries Show 3 more changesShow less
    • Primary completion date changed from estimate of Mar 31, 2026 to Apr 23, 2026
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 4 of 23 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to understand the incidence of transfusion dependent lower-risk myelodysplastic syndromes (TD LR-MDS) and describing real-world first-line treatment patterns, healthcare resource utilization, and associated clinical outcomes in adult patients with TD LR-MDS in Spain
Trial Details
NCT Number NCT07465029
Lead Sponsor Bristol-Myers Squibb
Conditions Lower-risk Myelodysplastic Syndromes (TD LR-MDS)
Enrollment 1,300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov